Esophageal Cancer Awareness Month: Paradigm Shifts in Targetable Disease
In an interview with Targeted Oncology for Esophageal Cancer Awareness Month, Arturo Loaiza-Bonilla, MD, MSEd, discussed the pressing need to keep up with the developments in targeted therapies for esophageal and GEJ cancers.
PSOH Members Recognized for Outstanding Legislative Leadership by ASCO
PSOH gives its congratulations to Edward Balaban, DO, FACP, FASCO and Marilyn Heine, MD for being awarded at the ASCO Advocacy Summit.
The Impact of CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma
The paradigm for management of relapsed myeloma is evolving rapidly with a plethora of treatment options based on results of clinical trials. One explosive area of scientific and clinical research is the investigation of chimeric antigen receptor T-cell therapy.
COVID-19 and Its Impact on Oncology Clinical Trials
Coronavirus disease 2019 has disrupted oncologic care across the spectrum of cancer screening, diagnosis, and management.
Targeted Oncology™ Announces the Addition of Pennsylvania Society of Oncology and Hematology to Its Strategic Alliance Partnership Program
Targeted Oncology, a multimedia resource that offers engaging content and expert opinions on standard and emerging treatments in the field of oncology, has added the Pennsylvania Society of Oncology and Hematology to its Strategic Alliance Partnership program.
Pennsylvania Society of Oncology & Hematology Welcomes Arturo Loiaza-Bonilla, MD, MSEd, as New President
Arturo Loaiza-Bonilla, MD, MSEd, FACP ascended to the presidency of the Pennsylvania Society of Oncology, albeit virtually, during the society’s Annual Scientific Conference held via ZOOM on September 25.
2 Clarke Drive Cranbury, NJ 08512